Allergy medication doesn't work for everyone all of the time — and if your antihistamines or nasal sprays seem less effective than they once were, there are several well-recognised reasons why. From changes in allergen exposure and incorrect inhaler technique to undertreated co-existing conditions and rebound congestion from overused decongestant sprays, the causes are often identifiable and addressable. This article explains why allergy treatments can appear to fail, when to seek a GP review, and what alternative options — including allergen immunotherapy and biologic therapies — are available through the NHS.
Summary: When allergy medication doesn't work, the most common reasons include inconsistent use, increased allergen exposure, incorrect technique, or an undertreated co-existing condition rather than true drug failure.
- Second-generation antihistamines (e.g. cetirizine, loratadine) are preferred over first-generation (e.g. chlorphenamine) for regular use due to longer action and fewer side effects.
- NICE CKS recommends intranasal corticosteroids as first-line treatment for moderate-to-severe or persistent allergic rhinitis, often alongside an antihistamine.
- Prolonged use of topical nasal decongestants (e.g. xylometazoline) beyond 5–7 days can cause rebound congestion (rhinitis medicamentosa), mimicking worsening allergy.
- Allergen immunotherapy (SCIT or SLIT) is available on the NHS for selected conditions and must be initiated and supervised by a specialist allergy service.
- Montelukast carries an MHRA safety warning (2020) regarding neuropsychiatric side effects, including mood changes and sleep disturbances; patients should be counselled before starting.
- Anyone who has experienced suspected anaphylaxis should be referred to a specialist allergy service in line with NICE guideline NG183.
Table of Contents
- Why Your Allergy Medication May Stop Working
- Common Reasons Antihistamines and Other Treatments Lose Effect
- When to Review Your Allergy Treatment With a GP
- Alternative Allergy Treatments Available on the NHS
- How UK Clinical Guidelines Approach Difficult-to-Treat Allergies
- Getting a Referral to an NHS Allergy Specialist
- Frequently Asked Questions
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
Why Your Allergy Medication May Stop Working
If you have noticed that your allergy medication does not work as well as it once did, you are not alone. Many people find that treatments which previously controlled their symptoms — such as sneezing, itchy eyes, or skin reactions — seem to become less effective over time. Understanding why this happens is the first step towards finding a more suitable approach.
Allergic conditions are not static. The immune system's response to allergens can change over months and years, meaning the pattern and severity of your symptoms may shift. For example, seasonal allergic rhinitis (hay fever) can worsen as pollen counts rise or as you are exposed to new allergens. Similarly, conditions such as allergic asthma or eczema may fluctuate in response to environmental, hormonal, or lifestyle changes.
It is also worth considering whether your exposure to the trigger allergen has increased. Moving home, changing jobs, acquiring a pet, or spending more time outdoors can all significantly raise your allergen load. When the burden of allergen exposure exceeds what your current medication can manage, symptoms will break through — even if the medication itself is working as intended. In these cases, the issue is not necessarily that the drug has failed, but that the clinical situation has changed around it.
Two commonly overlooked reasons for apparent loss of efficacy are poor adherence and incorrect technique. Antihistamine tablets taken only occasionally, or nasal sprays used incorrectly (for example, directing the spray towards the nasal septum rather than away from it), will not provide consistent relief. Reviewing how and when you take your medication is often the most straightforward first step.
If you use an over-the-counter decongestant nasal spray (such as xylometazoline or oxymetazoline) regularly, it is important to be aware that these should not be used for more than five to seven consecutive days. Prolonged use can cause rebound congestion — a condition known as rhinitis medicamentosa — in which the nasal lining becomes dependent on the spray and congestion worsens when it is stopped. This can be mistaken for worsening allergy but requires a different approach to manage.
Common Reasons Antihistamines and Other Treatments Lose Effect
There are several well-recognised reasons why antihistamines and other allergy medications may appear to lose their effectiveness:
-
Adherence and timing: Antihistamines work best when taken regularly during your allergy season or before known exposure, rather than only once symptoms are already severe. Taking them reactively means the drug is playing catch-up rather than preventing the histamine response. For predictable triggers such as grass pollen, starting treatment a few days before the season begins can improve control.
-
Reduced efficacy attributed to 'tolerance': Some patients report reduced benefit after prolonged use of the same antihistamine. True pharmacological tolerance to modern second-generation antihistamines is not well established in the clinical literature, and a more likely explanation is changing allergen exposure, worsening underlying disease, or inconsistent use. If you feel your antihistamine is no longer helping, discuss this with a pharmacist or GP before assuming tolerance has developed.
-
Incorrect medication class: First-generation antihistamines (such as chlorphenamine) cause sedation, have a shorter duration of action, and are generally less suitable for regular use. Switching to a non-sedating second-generation antihistamine (such as cetirizine or loratadine) may provide more consistent, longer-lasting relief. Note that fexofenadine 120 mg for allergic rhinitis is a prescription-only medicine in the UK and should be discussed with your GP.
-
Intranasal corticosteroids not being used: For allergic rhinitis, NICE CKS guidance recommends a non-sedating oral antihistamine for mild or intermittent symptoms, but an intranasal corticosteroid (such as beclometasone or fluticasone) as the preferred treatment for moderate-to-severe or persistent symptoms, often in combination with an antihistamine. Many patients rely solely on antihistamines and miss the anti-inflammatory benefit that nasal sprays provide. Combination intranasal sprays containing both an antihistamine and a corticosteroid (such as azelastine with fluticasone) are also available on prescription for uncontrolled symptoms.
-
Undertreated co-existing conditions: Conditions such as non-allergic rhinitis, sinusitis, nasal polyps, or asthma can mimic or worsen allergy symptoms. If these are not addressed, antihistamines alone will not provide full relief. For prominent watery nasal discharge, your GP may consider an intranasal ipratropium spray.
-
Decongestant spray overuse: As noted above, rebound congestion from prolonged use of topical nasal decongestants can cause persistent nasal blockage that antihistamines will not resolve.
Important safety information:
-
First-generation (sedating) antihistamines such as chlorphenamine impair your ability to drive or operate machinery. Do not drive or use heavy machinery if you are affected. Alcohol increases sedation and should be avoided.
-
Do not take more than the recommended dose of any antihistamine, and do not take two different oral antihistamines at the same time.
-
If you experience any unexpected side effects from your allergy medication, you can report these to the Medicines and Healthcare products Regulatory Agency (MHRA) via the Yellow Card scheme at yellowcard.mhra.gov.uk.
Antihistamines block H1 histamine receptors, reducing the immediate allergic response. However, they do not address the underlying inflammatory cascade, which is why corticosteroids are often needed alongside them for more persistent or moderate-to-severe symptoms.
When to Review Your Allergy Treatment With a GP
Knowing when to seek a GP review is important for both safety and effective symptom management. You should consider booking an appointment if:
-
Your symptoms are no longer controlled by over-the-counter antihistamines or nasal sprays
-
You are taking allergy medication daily for more than four weeks without adequate relief
-
Your symptoms are significantly affecting your sleep, work, or quality of life
-
You have developed new symptoms, such as breathlessness, chest tightness, or a persistent cough, which may suggest allergic asthma
-
You have severe eye symptoms, including eye pain or changes in vision, which require prompt assessment
-
You have persistent one-sided nasal blockage or recurrent nosebleeds, which should be assessed to exclude other causes
-
You have experienced a severe allergic reaction (anaphylaxis), including throat swelling, difficulty breathing, or collapse — call 999 immediately. Anyone who has been treated for suspected anaphylaxis should subsequently be referred to a specialist allergy service for assessment and follow-up, in line with NICE guideline NG183
-
You are unsure which allergen is triggering your symptoms
A GP can review your current medication regimen, assess whether you are using treatments correctly, and consider whether a step-up in therapy is appropriate. They may also arrange allergy testing, such as a skin prick test or specific IgE blood test, to help identify your triggers. These tests are most useful when guided by your clinical history and are typically carried out in specialist settings.
It is also worth discussing any other medications you take with your GP. Beta-blockers may reduce the effectiveness of adrenaline (epinephrine) used to treat anaphylaxis, and ACE inhibitors are associated with an increased risk of angioedema. You should not stop either of these medicines without medical advice, but your GP can review the risks and adjust your overall management plan accordingly.
Alternative Allergy Treatments Available on the NHS
When standard antihistamines and intranasal corticosteroids are insufficient, there are several alternative or adjunctive treatments available through the NHS that your GP or specialist may consider.
Allergen immunotherapy (desensitisation) is one of the most significant options. This involves gradually exposing the immune system to increasing amounts of an allergen — either via subcutaneous injections (SCIT) or sublingual tablets or drops (SLIT) — with the aim of inducing long-term tolerance. Immunotherapy is available on the NHS for conditions including allergic rhinitis due to grass pollen or house dust mite (for example, sublingual house dust mite tablets such as Acarizax), and for bee or wasp venom allergy. It requires a commitment of three to five years but can produce lasting benefit beyond the treatment period.
Importantly, immunotherapy must be initiated and supervised by a specialist allergy service. It is not suitable for everyone. Key contraindications include uncontrolled or severe asthma. Beta-blockers are a contraindication to SCIT because they may impair the response to adrenaline if a systemic reaction occurs; ACE inhibitors require caution with venom immunotherapy. Your specialist will assess your suitability before starting treatment and will advise on the risk of systemic allergic reactions, which, although uncommon, can occur.
Monoclonal antibody therapy represents a newer approach for difficult-to-treat allergic conditions. Omalizumab (Xolair), a biologic that targets immunoglobulin E (IgE), is approved by NICE for severe allergic asthma and chronic spontaneous urticaria in adults and children meeting specific eligibility criteria. By binding free IgE, it reduces the immune system's ability to trigger allergic responses. It is administered by injection every two to four weeks and is available through specialist centres.
Other options your GP or specialist may discuss include:
-
Leukotriene receptor antagonists (such as montelukast) for allergic rhinitis or asthma. The MHRA has issued a safety warning (2020) that montelukast can cause neuropsychiatric reactions, including sleep disturbances, mood changes, and, rarely, suicidal thoughts. Patients and carers should be made aware of these risks before starting treatment and should seek medical advice promptly if such symptoms occur.
-
Topical corticosteroids for eczema or allergic skin conditions
-
Sodium cromoglicate eye drops for allergic conjunctivitis
-
Short courses of oral corticosteroids for severe, acute flare-ups, used cautiously and only when clinically necessary due to the risk of side effects with repeated or prolonged use
For severe eosinophilic or allergic asthma, NICE has approved several additional biologic agents — including mepolizumab, dupilumab, benralizumab, and tezepelumab — for patients meeting specific phenotype-based eligibility criteria. These are available through specialist severe asthma services.
How UK Clinical Guidelines Approach Difficult-to-Treat Allergies
Several authoritative UK bodies provide evidence-based guidance to support clinicians in managing allergic conditions across a range of severity levels.
For allergic rhinitis, NICE CKS and BSACI/ARIA guidance recommend a stepwise approach based on symptom severity and pattern. A non-sedating oral antihistamine is appropriate for mild or intermittent symptoms. An intranasal corticosteroid is preferred for moderate-to-severe or persistent symptoms, either alone or in combination with an antihistamine. If symptoms remain uncontrolled, combination intranasal antihistamine–corticosteroid sprays or referral to a specialist should be considered. Correct nasal spray technique — directing the spray laterally away from the nasal septum — is emphasised as important for both efficacy and safety.
For allergic asthma, NICE guideline NG80 and the BTS/SIGN asthma guideline (which are separate documents) both advocate a stepwise treatment model, moving from short-acting bronchodilators through inhaled corticosteroids and long-acting beta-agonists, and ultimately to add-on therapies for severe, refractory disease. NICE technology appraisals have approved several biologic agents — including omalizumab, mepolizumab, dupilumab, benralizumab, and tezepelumab — for specific severe allergic or eosinophilic asthma phenotypes, with defined eligibility criteria.
NICE also recognises the importance of accurate allergy diagnosis. Its guideline on food allergy in children (CG116) and broader allergy pathway guidance emphasise that clinical history, combined with validated allergy testing, should underpin all management decisions. Empirical treatment without identifying the underlying trigger is discouraged, as it can lead to prolonged ineffective therapy and delayed appropriate care.
Patient education and self-management are central to good outcomes across all guidelines. Understanding how to use nasal sprays and inhalers correctly, adhering to regular dosing schedules, and recognising early signs of deterioration all contribute meaningfully to treatment success.
Getting a Referral to an NHS Allergy Specialist
If your allergy medication does not work despite optimised first- and second-line treatment, a referral to an NHS allergy specialist is the appropriate next step. Your GP can refer you to a consultant allergist or immunologist, typically based at an NHS allergy clinic, for comprehensive assessment and management.
Common reasons for referral include:
-
Symptoms not controlled despite appropriate first- and second-line treatment
-
Suspected food or drug allergy requiring formal assessment
-
Venom allergy (bee or wasp) with a history of systemic reactions
-
Occupational allergy
-
Chronic spontaneous urticaria not controlled on high-dose antihistamines
-
Recurrent or previous anaphylaxis (in line with NICE NG183, specialist referral is recommended after any episode of suspected anaphylaxis)
-
Consideration of allergen immunotherapy
During a specialist appointment, you can expect:
-
A detailed clinical history, including symptom patterns, potential triggers, occupational exposures, and family history of atopy
-
Allergy testing, which may include skin prick testing or specific IgE blood tests (previously known as RAST tests), guided by your clinical history
-
Intradermal testing in selected cases, typically for suspected venom or drug allergy (not routinely used for food allergy)
-
Challenge testing in some cases, carried out under controlled conditions to confirm or exclude specific allergies
-
A tailored management plan, which may include immunotherapy, biologic therapy, or specialist-led education
It is worth noting that NHS allergy services are unevenly distributed across the UK, and waiting times can vary significantly by region. The British Society for Allergy and Clinical Immunology (BSACI) maintains a directory of allergy services that GPs can consult when identifying the appropriate referral pathway.
In the meantime, keeping a symptom diary — noting when symptoms occur, their severity, and any potential triggers — can be extremely helpful for your specialist appointment. This information, combined with a clear record of treatments tried and their outcomes, will enable the allergist to make a more accurate diagnosis and recommend the most appropriate next steps for your care.
If you experience any suspected side effects from your allergy medicines, you can report them to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.
Experiencing these side effects? Our pharmacists can help you navigate them →
Frequently Asked Questions
Why has my allergy medication suddenly stopped working after years of being fine?
Allergic conditions change over time, and an increase in allergen exposure — due to a new pet, a change in environment, or a particularly high pollen season — can overwhelm a medication that previously kept symptoms under control. It is also worth reviewing whether you are taking your antihistamine regularly and using any nasal spray with the correct technique, as these are common and easily corrected reasons for apparent loss of effect.
Can you build up a tolerance to antihistamines so they stop working?
True pharmacological tolerance to modern second-generation antihistamines (such as cetirizine or loratadine) is not well established in clinical evidence. A more likely explanation for reduced benefit is worsening underlying disease, increased allergen exposure, or inconsistent use rather than the body becoming immune to the drug. If your antihistamine no longer seems effective, speak to a pharmacist or GP before switching or increasing your dose.
What is the difference between antihistamines and intranasal corticosteroid sprays for allergies?
Antihistamines block histamine receptors to reduce the immediate allergic response — such as sneezing and itching — but do not address the underlying nasal inflammation. Intranasal corticosteroids (e.g. beclometasone, fluticasone) reduce that inflammation directly and are recommended by NICE as the preferred treatment for moderate-to-severe or persistent allergic rhinitis, often used alongside an antihistamine for best effect.
Is allergy medication safe to take every day long term?
Non-sedating second-generation antihistamines and intranasal corticosteroids are generally considered safe for regular, long-term use when taken as directed. However, topical nasal decongestant sprays (e.g. xylometazoline) must not be used for more than five to seven consecutive days, as prolonged use causes rebound congestion. If you are taking any allergy medication daily for more than four weeks without adequate relief, a GP review is recommended.
How do I get a referral to an NHS allergy specialist if my allergy medication doesn't work?
Ask your GP for a referral to an NHS allergy clinic if your symptoms remain uncontrolled despite appropriate first- and second-line treatments, or if you have had a severe allergic reaction, suspected food or drug allergy, or venom allergy. Your GP can identify the appropriate local service using the BSACI directory of allergy clinics, though waiting times vary by region across the UK.
What is allergen immunotherapy and can I get it on the NHS?
Allergen immunotherapy (desensitisation) involves gradually exposing the immune system to increasing amounts of an allergen — via injections or sublingual tablets — to build long-term tolerance, and it is available on the NHS for conditions such as grass pollen or house dust mite allergic rhinitis and bee or wasp venom allergy. It requires a commitment of three to five years and must be initiated and supervised by a specialist allergy service, as it is not suitable for everyone — particularly those with uncontrolled asthma.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
